381 related articles for article (PubMed ID: 22469244)
1. Human aortic endothelial cell labeling with positive contrast gadolinium oxide nanoparticles for cellular magnetic resonance imaging at 7 Tesla.
Loai Y; Sakib N; Janik R; Foltz WD; Cheng HL
Mol Imaging; 2012 Apr; 11(2):166-75. PubMed ID: 22469244
[TBL] [Abstract][Full Text] [Related]
2. Properties evaluation of a new MRI contrast agent based on Gd-loaded nanoparticles.
Riyahi-Alam N; Behrouzkia Z; Seifalian A; Haghgoo Jahromi S
Biol Trace Elem Res; 2010 Dec; 137(3):324-34. PubMed ID: 20049554
[TBL] [Abstract][Full Text] [Related]
3. Rapid synthesis of PEGylated ultrasmall gadolinium oxide nanoparticles for cell labeling and tracking with MRI.
Faucher L; Tremblay M; Lagueux J; Gossuin Y; Fortin MA
ACS Appl Mater Interfaces; 2012 Sep; 4(9):4506-15. PubMed ID: 22834680
[TBL] [Abstract][Full Text] [Related]
4. Synthesis and characterization of PEGylated Gd2O3 nanoparticles for MRI contrast enhancement.
Ahrén M; Selegård L; Klasson A; Söderlind F; Abrikossova N; Skoglund C; Bengtsson T; Engström M; Käll PO; Uvdal K
Langmuir; 2010 Apr; 26(8):5753-62. PubMed ID: 20334417
[TBL] [Abstract][Full Text] [Related]
5. Cationic Gd-DTPA liposomes for highly efficient labeling of mesenchymal stem cells and cell tracking with MRI.
Guenoun J; Koning GA; Doeswijk G; Bosman L; Wielopolski PA; Krestin GP; Bernsen MR
Cell Transplant; 2012; 21(1):191-205. PubMed ID: 21929868
[TBL] [Abstract][Full Text] [Related]
6. Gadolinium-conjugated PLA-PEG nanoparticles as liver targeted molecular MRI contrast agent.
Chen Z; Yu D; Liu C; Yang X; Zhang N; Ma C; Song J; Lu Z
J Drug Target; 2011 Sep; 19(8):657-65. PubMed ID: 21091273
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous silica nanoparticles as a delivery system of gadolinium for effective human stem cell tracking.
Hsiao JK; Tsai CP; Chung TH; Hung Y; Yao M; Liu HM; Mou CY; Yang CS; Chen YC; Huang DM
Small; 2008 Sep; 4(9):1445-52. PubMed ID: 18680095
[TBL] [Abstract][Full Text] [Related]
8. Gadolinium hexanedione nanoparticles for stem cell labeling and tracking via magnetic resonance imaging.
Tseng CL; Shih IL; Stobinski L; Lin FH
Biomaterials; 2010 Jul; 31(20):5427-35. PubMed ID: 20400176
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of poly(L-glutamic acid) gadolinium chelate: a new biodegradable MRI contrast agent.
Wen X; Jackson EF; Price RE; Kim EE; Wu Q; Wallace S; Charnsangavej C; Gelovani JG; Li C
Bioconjug Chem; 2004; 15(6):1408-15. PubMed ID: 15546209
[TBL] [Abstract][Full Text] [Related]
10. Gd-DTPA T1 relaxivity in brain tissue obtained by convection-enhanced delivery, magnetic resonance imaging and emission spectroscopy.
Haar PJ; Broaddus WC; Chen ZJ; Fatouros PP; Gillies GT; Corwin FD
Phys Med Biol; 2010 Jun; 55(12):3451-65. PubMed ID: 20508321
[TBL] [Abstract][Full Text] [Related]
11. Gd₂O₃ nanoparticles in hematopoietic cells for MRI contrast enhancement.
Hedlund A; Ahrén M; Gustafsson H; Abrikossova N; Warntjes M; Jönsson JI; Uvdal K; Engström M
Int J Nanomedicine; 2011; 6():3233-40. PubMed ID: 22228991
[TBL] [Abstract][Full Text] [Related]
12. Targeted dual-contrast T1- and T2-weighted magnetic resonance imaging of tumors using multifunctional gadolinium-labeled superparamagnetic iron oxide nanoparticles.
Yang H; Zhuang Y; Sun Y; Dai A; Shi X; Wu D; Li F; Hu H; Yang S
Biomaterials; 2011 Jul; 32(20):4584-93. PubMed ID: 21458063
[TBL] [Abstract][Full Text] [Related]
13. Nanotemplate-engineered nanoparticles containing gadolinium for magnetic resonance imaging of tumors.
Zhu D; Lu X; Hardy PA; Leggas M; Jay M
Invest Radiol; 2008 Feb; 43(2):129-40. PubMed ID: 18197065
[TBL] [Abstract][Full Text] [Related]
14. Development of a novel lipidic nanoparticle probe using liposomal encapsulated Gd₂O₃-DEG for molecular MRI.
Zohdiaghdam R; Riyahi-Alam N; Moghimi HR; Haghgoo S; Alinaghi A; Azizian G; Ghanaati H; Gorji E; Rafiei B
J Microencapsul; 2013; 30(7):613-23. PubMed ID: 23915304
[TBL] [Abstract][Full Text] [Related]
15. Gadolinium-labeled peptide dendrimers with controlled structures as potential magnetic resonance imaging contrast agents.
Luo K; Liu G; She W; Wang Q; Wang G; He B; Ai H; Gong Q; Song B; Gu Z
Biomaterials; 2011 Nov; 32(31):7951-60. PubMed ID: 21784511
[TBL] [Abstract][Full Text] [Related]
16. Gadolinium-fullerenol as a paramagnetic contrast agent for cellular imaging.
Anderson SA; Lee KK; Frank JA
Invest Radiol; 2006 Mar; 41(3):332-8. PubMed ID: 16481917
[TBL] [Abstract][Full Text] [Related]
17. Impact of agglomeration on the relaxometric properties of paramagnetic ultra-small gadolinium oxide nanoparticles.
Faucher L; Gossuin Y; Hocq A; Fortin MA
Nanotechnology; 2011 Jul; 22(29):295103. PubMed ID: 21693804
[TBL] [Abstract][Full Text] [Related]
18. A novel gadolinium-based trimetasphere metallofullerene for application as a magnetic resonance imaging contrast agent.
Adiseshaiah P; Dellinger A; MacFarland D; Stern S; Dobrovolskaia M; Ileva L; Patri AK; Bernardo M; Brooks DB; Zhou Z; McNeil S; Kepley C
Invest Radiol; 2013 Nov; 48(11):745-54. PubMed ID: 23748228
[TBL] [Abstract][Full Text] [Related]
19. Analysis of feasibility of in vitro nuclear magnetic resonance tracking human umbilical cord mesenchymal stem cells by Gd-DTPA labeled.
Shuai HL; Yan RL; Song H; Chen DL; Luo X
Magn Reson Imaging; 2014 Sep; 32(7):934-40. PubMed ID: 24794127
[TBL] [Abstract][Full Text] [Related]
20. Enhancement of relaxivity rates of Gd-DTPA complexes by intercalation into layered double hydroxide nanoparticles.
Xu ZP; Kurniawan ND; Bartlett PF; Lu GQ
Chemistry; 2007; 13(10):2824-30. PubMed ID: 17186555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
